Entity Health has created a novel dietary supplement, in which the oxidised form of nicotinamide adenine dinucleotide, also known as NAD+, could be delivered in the form of sublingual wafers.
Ingredients with poor bioavailability, such as curcumin, can be applied in new nutraceutical product formats, including stick sachets, juice, and oral spray, with the use of advanced delivery technologies.